Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
Tetravalent Dengue Vaccine Candidate Shows Promise in Early Trials Medical Countermeasures January 28, 2013 …
Emergent BioSolutions Secures Rights to Pandemic Influenza Vaccine Candidate Industry News January 8, 2013 …
DARPA Supports Research on Pollen for Oral Vaccine Delivery Medical Countermeasures November 28, 2012 …
Army Dengue Vaccine Trial Supported by State University of New York Industry News November 28, 2012 …
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine Industry News November 23, 2012 …
Open Access Initiative Helps Neglected Tropical Disease Drug Effort Industry News November 13, 2012 …
NIH, CDC Small Business Innovation for Medical Countermeasures Contracts + Grants November 12, 2012 …
DTRA to Advance Nanostructured Therapeutics for Chem-Bio Defense Contracts + Grants October 22, 2012 …
